Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in Net LoansChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Beginning Cash Balance (2018 - 2019)

Abvc Biopharma (ABVC) has disclosed Beginning Cash Balance for 2 consecutive years, with $360000.0 as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Beginning Cash Balance changed N/A year-over-year to $360000.0, compared with a TTM value of $820000.0 through Dec 2019, up 219.07%, and an annual FY2019 reading of $820000.0, up 219.07% over the prior year.
  • Beginning Cash Balance was $360000.0 for Q3 2019 at Abvc Biopharma, down from $460000.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $460000.0 in Q1 2019 and bottomed at $13087.0 in Q1 2018.